JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gotoh, Y.
Right arrow Articles by Sugiyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gotoh, Y.
Right arrow Articles by Sugiyama, Y.

Vol. 292, Issue 1, 433-439, January 2000

Involvement of an Organic Anion Transporter (Canalicular Multispecific Organic Anion Transporter/Multidrug Resistance-Associated Protein 2) in Gastrointestinal Secretion of Glutathione Conjugates in Rats

Yasumasa Gotoh, Hiroshi Suzuki , Setsuo Kinoshita, Tomoko Hirohashi , Yukio Kato and Yuichi Sugiyama

Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo (Y.G., H.S., S.K., T.H., Y.K., Y.S.); and Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Kawaguchi City, Japan (H.S., T.H., Y.K.,Y.S.)

We investigated the role of cMOAT/MRP2 (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in the intestinal secretion of organic anions by comparing the behavior in Sprague-Dawley (SD) rats and Eisai hyperbilirubinemic rat (EHBR) whose cMOAT/MRP2 is hereditarily defective. After i.v. administration of 1-chloro-2,4-dinitrobenzene (30 µmol/kg), the biliary and intestinal excretion of its glutathione conjugate 2,4-dinitrophenyl-S-glutathione (DNP-SG), a substrate for cMOAT/MRP2, was significantly reduced in EHBR compared with SD rats. This result also was confirmed by Ussing chamber studies; DNP-SG showed 1.5-fold greater serosal-to-mucosal flux compared with the mucosal-to-serosal flux in SD rats, whereas a similar flux was observed in both directions in EHBR. In addition, metabolic inhibitors reduced the preferential serosal-to-mucosal flux of DNP-SG in SD rats. In everted sac studies, intestinal secretion clearance, defined as the efflux rate of DNP-SG into the mucosal side divided by the area under the curve on the serosal side, was significantly lower in the jejunum of EHBR than that in SD rats. Northern blot analyses demonstrated the highest mRNA level of cMOAT/MRP2 in the jejunum, which is in good agreement with the results of the everted sac studies. These results suggest that cMOAT/MRP2 is involved in the secretion of organic anions in the small intestine.

0022-3565/0/2921-0433$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
T. Makino, N. Ohtake, A. Watanabe, N. Tsuchiya, S. Imamura, S. Iizuka, M. Inoue, and H. Mizukami
Down-Regulation of a Hepatic Transporter Multidrug Resistance-Associated Protein 2 Is Involved in Alteration of Pharmacokinetics of Glycyrrhizin and Its Metabolites in a Rat Model of Chronic Liver Injury
Drug Metab. Dispos., July 1, 2008; 36(7): 1438 - 1443.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. MacLean, U. Moenning, A. Reichel, and G. Fricker
Closing the Gaps: A Full Scan of the Intestinal Expression of P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 in Male and Female Rats
Drug Metab. Dispos., July 1, 2008; 36(7): 1249 - 1254.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. S. M. Villanueva, M. L. Ruiz, C. I. Ghanem, M. G. Luquita, V. A. Catania, and A. D. Mottino
Hepatic Synthesis and Urinary Elimination of Acetaminophen Glucuronide Are Exacerbated in Bile Duct-Ligated Rats
Drug Metab. Dispos., March 1, 2008; 36(3): 475 - 480.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. Enokizono, H. Kusuhara, and Y. Sugiyama
Regional Expression and Activity of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Mouse Intestine: Overlapping Distribution with Sulfotransferases
Drug Metab. Dispos., June 1, 2007; 35(6): 922 - 928.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. S. M. Villanueva, M. L. Ruiz, C. J. Soroka, S.-Y. Cai, M. G. Luquita, A. M. Torres, E. J. Sanchez Pozzi, J. M. Pellegrino, J. L. Boyer, V. A. Catania, et al.
HEPATIC AND EXTRAHEPATIC SYNTHESIS AND DISPOSITION OF DINITROPHENYL-S-GLUTATHIONE IN BILE DUCT-LIGATED RATS
Drug Metab. Dispos., August 1, 2006; 34(8): 1301 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
S. Choudhuri and C. D. Klaassen
Structure, Function, Expression, Genomic Organization, and Single Nucleotide Polymorphisms of Human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) Efflux Transporters
International Journal of Toxicology, July 1, 2006; 25(4): 231 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Yamaguchi, Y. L. Zhao, M. Nadai, H. Yoshizumi, X. Cen, S. Torita, K. Takagi, K. Takagi, and T. Hasegawa
Involvement of the Drug Transporters P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 in Telithromycin Transport
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 80 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. T. Kivisto, O. Grisk, U. Hofmann, K. Meissner, K.-U. Moritz, C. Ritter, K. A. Arnold, D. Lutjoohann, K. von Bergmann, I. Kloting, et al.
DISPOSITION OF ORAL AND INTRAVENOUS PRAVASTATIN IN MRP2-DEFICIENT TR- RATS
Drug Metab. Dispos., November 1, 2005; 33(11): 1593 - 1596.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
S. S. M. Villanueva, M. L. Ruiz, M. G. Luquita, E. J. Sanchez Pozzi, V. A. Catania, and A. D. Mottino
Involvement of Mrp2 in Hepatic and Intestinal Disposition of Dinitrophenyl-S-glutathione in Partially Hepatectomized Rats
Toxicol. Sci., March 1, 2005; 84(1): 4 - 11.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y. Adachi, H. Suzuki, A. H. Schinkel, and Y. Sugiyama
Role of Breast Cancer Resistance Protein (Bcrp1/Abcg2) in the Extrusion of Glucuronide and Sulfate Conjugates from Enterocytes to Intestinal Lumen
Mol. Pharmacol., March 1, 2005; 67(3): 923 - 928.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Shoji, H. Suzuki, H. Kusuhara, Y. Watanabe, S. Sakamoto, and Y. Sugiyama
ATP-dependent transport of organic anions into isolated basolateral membrane vesicles from rat intestine
Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G749 - G756.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Sugie, E. Asakura, Y. L. Zhao, S. Torita, M. Nadai, K. Baba, K. Kitaichi, K. Takagi, K. Takagi, and T. Hasegawa
Possible Involvement of the Drug Transporters P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 in Disposition of Azithromycin
Antimicrob. Agents Chemother., March 1, 2004; 48(3): 809 - 814.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. S. Pang
MODELING OF INTESTINAL DRUG ABSORPTION: ROLES OF TRANSPORTERS AND METABOLIC ENZYMES (FOR THE GILLETTE REVIEW SERIES)
Drug Metab. Dispos., December 1, 2003; 31(12): 1507 - 1519.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Hu, J. Chen, and H. Lin
Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 314 - 321.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama
Impact of Drug Transporter Studies on Drug Discovery and Development
Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. Tam, R. G. Tirona, and K. S. Pang
Segmental Intestinal Transporters and Metabolic Enzymes on Intestinal Drug Absorption
Drug Metab. Dispos., April 1, 2003; 31(4): 373 - 383.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Hitzl, K. Klein, U. M. Zanger, P. Fritz, A. K. Nussler, P. Neuhaus, and M. F. Fromm
Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 524 - 530.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. H. Stephens, J. Tanianis-Hughes, N. B. Higgs, M. Humphrey, and G. Warhurst
Region-Dependent Modulation of Intestinal Permeability by Drug Efflux Transporters: In Vitro Studies in mdr1a(-/-) Mouse Intestine
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1095 - 1101.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Cao, B. Stieger, P. J. Meier, and M. Vore
Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy
Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G757 - G766.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. M. Gerk and M. Vore
Regulation of Expression of the Multidrug Resistance-Associated Protein 2 (MRP2) and Its Role in Drug Disposition
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 407 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
D. R. Johnson and C. D. Klaassen
Regulation of Rat Multidrug Resistance Protein 2 by Classes of Prototypical Microsomal Enzyme Inducers That Activate Distinct Transcription Pathways
Toxicol. Sci., June 1, 2002; 67(2): 182 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Rost, S. Mahner, Y. Sugiyama, and W. Stremmel
Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine
Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G720 - G726.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Hasegawa, H. Kusuhara, D. Sugiyama, K. Ito, S. Ueda, H. Endou, and Y. Sugiyama
Functional Involvement of Rat Organic Anion Transporter 3 (rOat3; Slc22a8) in the Renal Uptake of Organic Anions
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 746 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
D. R. Johnson, S. S. M. Habeebu, and C. D. Klaassen
Increase in Bile Flow and Biliary Excretion of Glutathione-Derived Sulfhydryls in Rats by Drug-Metabolizing Enzyme Inducers Is Mediated by Multidrug Resistance Protein 2
Toxicol. Sci., March 1, 2002; 66(1): 16 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. Naruhashi, I. Tamai, N. Inoue, H. Muraoka, Y. Sai, N. Suzuki, and A. Tsuji
Involvement of Multidrug Resistance-Associated Protein 2 in Intestinal Secretion of Grepafloxacin in Rats
Antimicrob. Agents Chemother., February 1, 2002; 46(2): 344 - 349.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. J. Cherrington, D. P. Hartley, N. Li, D. R. Johnson, and C. D. Klaassen
Organ Distribution of Multidrug Resistance Proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and Hepatic Induction of Mrp3 by Constitutive Androstane Receptor Activators in Rats
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 97 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. Cong, A. K. Y. Fong, R. Lee, and K. S. Pang
Absorption of Benzoic Acid in Segmental Regions of the Vascularly Perfused Rat Small Intestine Preparation
Drug Metab. Dispos., December 1, 2001; 29(12): 1539 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, H. Melhus, P. Garberg, B. Sjostrom, B. Lundgren, and P. Artursson
Correlation of Gene Expression of Ten Drug Efflux Proteins of the ATP-Binding Cassette Transporter Family in Normal Human Jejunum and in Human Intestinal Epithelial Caco-2 Cell Monolayers
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 164 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. D. Mottino, T. Hoffman, L. Jennes, J. Cao, and M. Vore
Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats
Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1261 - G1273.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. G. Dietrich, D.R. de Waart, R. Ottenhoff, A. H. Bootsma, A. H. van Gennip, and R. P.J.O. Elferink
Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
Carcinogenesis, May 1, 2001; 22(5): 805 - 811.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. G. Dietrich, D. R. de Waart, R. Ottenhoff, I. G. Schoots, and R. P. J. O. Elferink
Increased Bioavailability of the Food-Derived Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-Deficient Rats
Mol. Pharmacol., April 16, 2001; 59(5): 974 - 980.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. H. Stephens, C. A. O'Neill, A. Warhurst, G. L. Carlson, M. Rowland, and G. Warhurst
Kinetic Profiling of P-glycoprotein-Mediated Drug Efflux in Rat and Human Intestinal Epithelia
J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 584 - 591.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Okudaira, I. Komiya, and Y. Sugiyama
Polarized Efflux of Mono- and Diacid Metabolites of ME3229, an Ester-Type Prodrug of a Glycoprotein IIb/IIIa Receptor Antagonist, in Rat Small Intestine
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 717 - 723.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Okudaira, T. Tatebayashi, G. C. Speirs, I. Komiya, and Y. Sugiyama
A Study of the Intestinal Absorption of an Ester-Type Prodrug, ME3229, in Rats: Active Efflux Transport as a Cause of Poor Bioavailability of the Active Drug
J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 580 - 587.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. D. Mottino, T. Hoffman, L. Jennes, and M. Vore
Expression and Localization of Multidrug Resistant Protein mrp2 in Rat Small Intestine
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 717 - 723.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.